Autophagy, lipophagy and lysosomal lipid storage disorders DOI Creative Commons
Carl Ward, Nuria Martínez-López, Elsje G. Otten

et al.

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, Journal Year: 2016, Volume and Issue: 1861(4), P. 269 - 284

Published: Jan. 15, 2016

Autophagy is a catabolic process with an essential function in the maintenance of cellular and tissue homeostasis. It primarily recognised for its role degradation dysfunctional proteins unwanted organelles, however recent years range autophagy substrates has also been extended to lipids. Degradation lipids via termed lipophagy. The ability contribute lipo-homeostasis becomes particularly relevant context genetic lysosomal storage disorders where perturbations autophagic flux have suggested disease aetiology. Here we review discoveries molecular mechanisms mediating lipid turnover by pathways. We further focus on relevance autophagy, specifically lipophagy, mechanisms. Moreover, discussed as potential therapeutic target several key disorders.

Language: Английский

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty DOI
Luigi Ferrucci, Elisa Fabbri

Nature Reviews Cardiology, Journal Year: 2018, Volume and Issue: 15(9), P. 505 - 522

Published: July 31, 2018

Language: Английский

Citations

2510

mTOR: a pharmacologic target for autophagy regulation DOI Open Access
Young Chul Kim, Kun‐Liang Guan

Journal of Clinical Investigation, Journal Year: 2015, Volume and Issue: 125(1), P. 25 - 32

Published: Jan. 1, 2015

mTOR, a serine/threonine kinase, is master regulator of cellular metabolism. mTOR regulates cell growth and proliferation in response to wide range cues, its signaling pathway deregulated many human diseases. also plays crucial role regulating autophagy. This Review provides an overview the pathway, mechanisms autophagy regulation, clinical implications inhibitors disease treatment.

Language: Английский

Citations

1767

Small molecules in targeted cancer therapy: advances, challenges, and future perspectives DOI Creative Commons
Lei Zhong, Yueshan Li, Liang Xiong

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2021, Volume and Issue: 6(1)

Published: May 31, 2021

Abstract Due to the advantages in efficacy and safety compared with traditional chemotherapy drugs, targeted therapeutic drugs have become mainstream cancer treatments. Since first tyrosine kinase inhibitor imatinib was approved enter market by US Food Drug Administration (FDA) 2001, an increasing number of small-molecule been developed for treatment malignancies. By December 2020, 89 antitumor FDA National Medical Products (NMPA) China. Despite great progress, anti-cancer still face many challenges, such as a low response rate drug resistance. To better promote development we conducted comprehensive review according target classification. We present all well important candidates clinical trials each target, discuss current provide insights perspectives research drugs.

Language: Английский

Citations

1176

PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside DOI
Ali S. Alzahrani

Seminars in Cancer Biology, Journal Year: 2019, Volume and Issue: 59, P. 125 - 132

Published: July 16, 2019

Language: Английский

Citations

869

Cellular Senescence: A Translational Perspective DOI Creative Commons
James L. Kirkland, Tamar Tchkonia

EBioMedicine, Journal Year: 2017, Volume and Issue: 21, P. 21 - 28

Published: April 11, 2017

Cellular senescence entails essentially irreversible replicative arrest, apoptosis resistance, and frequently acquisition of a pro-inflammatory, tissue-destructive senescence-associated secretory phenotype (SASP). Senescent cells accumulate in various tissues with aging at sites pathogenesis many chronic diseases conditions. The SASP can contribute to senescence-related inflammation, metabolic dysregulation, stem cell dysfunction, phenotypes, diseases, geriatric syndromes, loss resilience. Delaying senescent accumulation or reducing burden is associated delay, prevention, alleviation multiple We used hypothesis-driven approach discover pro-survival Cell Anti-apoptotic Pathways (SCAPs) and, based on these SCAPs, the first senolytic agents, drugs that cause become susceptible their own pro-apoptotic microenvironment. Several which appear alleviate phenotypes pre-clinical models, are beginning process being translated into clinical interventions could be transformative.

Language: Английский

Citations

855

Metabolic Control of Autophagy DOI Creative Commons
Lorenzo Galluzzi, Federico Pietrocola, Beth Levine

et al.

Cell, Journal Year: 2014, Volume and Issue: 159(6), P. 1263 - 1276

Published: Dec. 1, 2014

Language: Английский

Citations

772

Tuberous sclerosis complex DOI
Elizabeth P. Henske, Sergiusz Jóźwiak, J.C. Kingswood

et al.

Nature Reviews Disease Primers, Journal Year: 2016, Volume and Issue: 2(1)

Published: May 26, 2016

Language: Английский

Citations

699

Metabolic Control of Longevity DOI Creative Commons
Carlos López-Otı́n, Lorenzo Galluzzi, José M.P. Freije

et al.

Cell, Journal Year: 2016, Volume and Issue: 166(4), P. 802 - 821

Published: Aug. 1, 2016

Language: Английский

Citations

674

Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates DOI Creative Commons

Daniel F. Egan,

Matthew G. H. Chun,

Mitchell Vamos

et al.

Molecular Cell, Journal Year: 2015, Volume and Issue: 59(2), P. 285 - 297

Published: June 25, 2015

Language: Английский

Citations

643

Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease DOI Creative Commons
Reuben L. Smith, Maarten R. Soeters, Rob C. I. Wüst

et al.

Endocrine Reviews, Journal Year: 2018, Volume and Issue: 39(4), P. 489 - 517

Published: April 24, 2018

The ability to efficiently adapt metabolism by substrate sensing, trafficking, storage, and utilization, dependent on availability requirement, is known as metabolic flexibility. In this review, we discuss the breadth depth of flexibility its impact health disease. Metabolic essential maintain energy homeostasis in times either caloric excess or restriction, low high demand, such during exercise. liver, adipose tissue, muscle govern systemic manage nutrient uptake, transport, expenditure communication via endocrine cues. At a molecular level, relies configuration pathways, which are regulated key enzymes transcription factors, many interact closely with mitochondria. Disrupted flexibility, inflexibility, however, associated pathological conditions including syndrome, type 2 diabetes mellitus, cancer. Multiple factors dietary composition feeding frequency, exercise training, use pharmacological compounds, influence will be discussed here. Last, outline important advances research medical horizons translational aspects.

Language: Английский

Citations

518